'Australian-first' cancer research facility opens at UQ

August 29, 2005

A 'state-of-the-art' cancer facility funded by a $1.2 million grant from the Australian Cancer Research Foundation (ACRF) was officially opened at the University of Queensland (UQ) today.

The ACRF Dynamic Imaging Facility for Cancer Biology- the only one of its kind in Australia - was launched by Parliamentary Secretary to the Queensland Minister for Health, Jo-Ann Miller MP.

The $1.2 million laboratory at UQ's Institute for Molecular Bioscience (IMB) houses two technologically advanced microscope systems which will enable cutting-edge research into cancer biology.

The IMB, is at the forefront of the latest global advances in cancer research" said ACRF Trustee Mr Tim Crommelin in Brisbane today. "The work underway at this new facility is laying the groundwork for the kind of major advances in cancer research that the Australian Cancer Research Foundation is committed to funding," he said.

IMB Director, Professor John Mattick said the $1.2 million grant was testament to the ACRF's foresight and commitment to invest in leading-edge cancer research facilities, and would improve Queensland's capacity to perform internationally competitive research.

"The uniqueness of the ACRF Dynamic Imaging Facility lies in the capacity of the microscope systems to offer IMB researchers new insight into the complex chemical messages cancer cells use to 'talk' to each other," said Professor Mattick. UQ's Deputy Vice-Chancellor (Research) Professor David Siddle congratulated the ACRF on their "iron-clad" commitment to funding initiatives that would help researchers to win the war on cancer.

"There are a variety of agencies funding research but the ACRF is fulfilling a critical role by providing large grants for infrastructure and equipment" Professor Siddle said.

The Australian Cancer Research Foundation - now in its 21st year of operation - has raised in excess of $36 million to support excellence in Australian research initiatives, and awarded grants totalling $6.3 million in the past two years.

Individual ACRF grants exceed $1 million - a sum not available from other private sources in Australia - and continue to significantly contribute to drastic breakthroughs in the fight against cancer.
Release online with background information at www.acrf.com.au

For media interviews contact:
Andrea Sackson - Institute for Molecular Bioscience Tel: +61 7 3346 2130 / Mob: 0414 672 318
Suzie Graham - Australian Cancer Research Foundation Mob: 0418 683 166 / sgraham@acrf.com.au

Research Australia

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.